The CF-ABLE score: A 2-year evaluation of a 4-year prognostic tool

J. Meurling, C. McCarthy, C. Gunaratnam, N. G. McElvaney (Dublin, Ireland)

Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Session: Cystic fibrosis: basic science, physiology and clinical aspects
Session type: Poster Discussion
Number: 1964

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Meurling, C. McCarthy, C. Gunaratnam, N. G. McElvaney (Dublin, Ireland). The CF-ABLE score: A 2-year evaluation of a 4-year prognostic tool. Eur Respir J 2014; 44: Suppl. 58, 1964

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predicting five year outcomes in adults with cystic fibrosis: Developing a predictive scoring model
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis
Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017
Year: 2017



Clinical value of lung clearance index (LCI) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Lung clearance Index changes over time among patients with cystic fibrosis
Source: International Congress 2015 – New findings in paediatric respiratory physiology
Year: 2015


Inflammatory biomarkers in urine of cystic fibrosis patients
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014


Annual change of LCI among patients with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016

Lung MRI findings in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014

Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


A new gold standard for assessing CT in early CF lung disease?
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014

Novel protein biomarkers of bronchiectasis in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014


National survey of hearing assessment in patients with cystic fibrosis in the UK
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


Screening colonoscopy in adults with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Evaluation of the effectiveness of cyclical and constant current on sweat volume and stimulation for cystic fibroses diagnoses
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014

Cystic fibrosis: paediatric
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

Cystic fibrosis: paediatric
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

Cystic fibrosis: paediatric
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Cystic fibrosis: paediatric
Source: ERS Skills Course 2016
Year: 2016

Difficulties in optimizing vitamin D levels in paediatric cystic fibrosis patients
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Hypoglycemia: An unrecognized problem in cystic fibrosis (CF) patients unmasked by continues glucose monitorisation (CGM)
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014